German vaccine panel recommends booster shots for over 70s
Reuters
Published Oct 07, 2021 08:43AM ET
Updated Oct 07, 2021 10:38AM ET
By Ludwig Burger and Riham Alkousaa
BERLIN (Reuters) -Germany's vaccine advisory committee on Thursday endorsed COVID-19 booster shots for those 70 years and older as well as medical staff interacting with patients, even as the nation's health system is already giving boosters to those over 60.
The expert panel, known as STIKO, said a repeat shot of mRNA vaccines by Pfizer-BioNTech or Moderna (NASDAQ:MRNA) should be given six months at the earliest after the initial standard course.
"Vaccine protection is decreasing over time in particular with regard to preventing asymptomatic infections and mild disease forms. With older age the immune response after vaccination takes an overall weaker form and breakthrough infections can more frequently lead to severe disease," STIKO said.
Anyone who received Johnson & Johnson (NYSE:JNJ)'s one-shot vaccine should get an mRNA booster four weeks after the initial dose because the rate of breakthrough infections for J&J's vaccine had been the highest among the approved shots, it added.
Decision makers in public health have not waited for the experts' word.
On Sept. 6, health ministers of the country's regional states and the federal minister Jens Spahn agreed to widen the groups eligible for a third shot to people over 60 who had consulted their physician.
They also included nursing home staff and anyone likely to work closely with infected people.
One month prior to that, the group decided to offer booster shots to people with weakened immune systems, people in nursery care and those over 80 years and people who received a full course of vector shots by AstraZeneca (NASDAQ:AZN) and J&J.
The European Union's drugs regulator said on Monday people with weakened immune systems should get a third dose of a vaccine from Pfizer-BioNTech or Moderna, but left it to member states to decide if the wider population should have a booster.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.